ONC Competitors & Alternatives
Compare BeiGene, Ltd. with similar stocks in the same industry
Biotechnology
ONC
Main Stock$297.65
Tradestie Score
59
Market Cap
$36.81B
P/E Ratio
65.8
Revenue Growth
0.4%
Analyst Upside
+38.5%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$939.68
|
$46.96B | 41.7 | 62 | Compare |
|
INSM
Insmed, Inc.
|
$111.60
|
$31.13B | - | 54 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$97.55
|
$24.57B | - | 56 | Compare |
|
GMAB
Genmab A/S ADS
|
$28.52
|
$19.56B | 20.9 | 63 | Compare |
|
INCY
Incyte Genomics Inc
|
$116.86
|
$16.93B | 16.1 | 61 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.77
|
$15.70B | 29.4 | 63 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.42
|
$15.22B | - | 49 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$274.50
|
$12.36B | 31.3 | 63 | Compare |
|
EXEL
Exelixis Inc
|
$55.85
|
$11.09B | 17.9 | 63 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.13
|
$10.76B | - | 59 | Compare |
More ONC Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry